TABLE 1

Demographic information

OligoG–PlaceboPlacebo–OligoGTotal
Subjects323365
 Male15 (46.9)16 (48.5)31 (47.7)
 Female17 (53.1)17 (51.5)34 (52.3)
Caucasian/European ethnic group32 (100)33 (100)65 (100)
Age at informed consent years31.8±10.335.3±8.933.5±9.7
19/31/59.319/36/5719/33/59.3
Height cm170.6±10.1170.4±8.2170.5±9.1
156.5/169.0/191154/172/184154/170/191
Body weight kg67.4±14.465.8±13.366.6±13.8
45.7/64.8/10342/62/9142/63.3/103
BMI kg·m223.07±4.0222.46±3.1722.76±3.59
17.63/22.40/34.3317.26/22.23/29.1317.26/22.30/34.33
FEV1 L2.437±0.7892.106±0.5582.269±0.697
1.42/2.260/4.331.20/2.060/3.511.20/2.120/4.33
FEV1 % predicted64.3±15.857.5±12.260.9±14.4
39/61.0/9739/57.2/8439/58.4/97

Data are presented as n, n (%), mean±sd or minimum/median/maximum. The baseline demographic characteristics were similar in the two treatment sequences. All subjects were of Caucasian/European origin. BMI: body mass index; FEV1: forced expiratory volume in 1 s.